Search the Newsreel

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend of $0.25 per share, payable on September 3rd to shareholders of record on August 20th. This announcement comes despite the company missing analyst expectations for both Q2 revenue and EPS, and subsequently lowering its full-year 2026 …

Boise Cascade (NYSE: BCC) director sells 1,930 shares at $84.58

Boise Cascade Co director Kristopher J. Matula sold 1,930 shares of common stock at $84.58 per share on August 5, 2026, in an open market or private transaction. Following this sale, Matula directly holds 13,982 shares of Boise Cascade common stock. The transaction was …

LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research

Ascentage Pharma Schedules Chinese and English Webcasts Aug. 19-20

Ascentage Pharma announced it will release its unaudited six-month 2026 interim results and provide a corporate update on August 19, 2026, at 7:00 am EDT / 7:00 pm HKT. The company will host a Mandarin investor webcast on August 19, 2026, and an English …

CapitaLand Ascendas REIT 1H Net Property Income S$556.1M Vs. S$523.4M >A17U.SG

CapitaLand Ascendas REIT : Revenue, income, and AUM rose YoY, with strong acquisitions and stable leverage

Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT

Royal Bank of Canada reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 6.3% in the first quarter, selling 18,448 shares but still retaining a significant holding of 272,654 shares valued at $29.8 million. This comes as LeMaitre Vascular reported Q2 earnings that missed …

What Keeps What Could Renascor Resources (ASX:RNU) on Watch This Reporting Season?

Will Cascades Inc. (CAS) Beat Estimates Again in Its Next Earnings Report?

Ascendis Pharma A/S

The article is a financial filing notification, specifically a Form 6K from Ascendis Pharma A/S, for April 8. It also includes general market data, news headlines, and stock performance figures, typical of a financial news platform.

LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ...

Why Is Boise Cascade (BCC) Stock Soaring Today

Boise Cascade (BCC) stock surged 5.8% after the company reported second-quarter earnings that beat Wall Street's expectations, with revenue growing 5.2% year-on-year and profit exceeding forecasts. Despite the strong Q2 results, the company's third-quarter adjusted EBITDA guidance fell short of analyst estimates. The stock's …

Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announced an opportunity for Erasca, Inc. (ERAS) shareholders who suffered losses to lead a securities fraud class action lawsuit. The lawsuit alleges that between January 14, 2025, and April 26, 2026, Erasca made materially false and misleading …

Boise Cascade (BCC) Stock Revenue Growth Masks A Sharper Margin Squeeze

Boise Cascade's Q2 2026 results showed a 5% revenue increase, leading to a stock jump, but net income declined by 8% and the trailing net profit margin compressed significantly from 4.0% to 1.6%. While Wood Products EBITDA improved due to better pricing and lower …

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates

LeMaitre Vascular (LMAT) reported Q2 earnings of $0.74 per share, falling short of the Zacks Consensus Estimate of $0.81, though it was an increase from $0.60 a year ago. The company's revenues of $70.38 million also missed expectations, despite being higher than the $64.23 …

LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) has lowered its third-quarter 2026 earnings guidance, projecting EPS of $0.660–$0.710 and revenue of $66.3–$68.3 million, both below analyst consensus. The company also updated its full-year 2026 EPS guidance to $2.840–$2.940. Despite the lowered outlook, analyst sentiment remains "Moderate Buy" with …

Boise Cascade Co (BCC) (Q2 2026) Earnings Call Highlights: Record Sales and Strategic Expansion ...

This article first appeared on GuruFocus. Consolidated Sales: $1.8 billion, up 5% year over year. Net Income: $57.3 million. Earnings Per Share (EPS): $1.63 per share. BMD Sales: $1.7 billion, up 5% from second-quarter 2025. BMD Segment EBITDA: $85.6 million, compared to $91.8 million …

How Investors Are Reacting To LeMaitre Vascular (LMAT) Slower Projected Revenue Growth And Mixed Earnings Track Record

Earnings call transcript: LeMaitre Vascular slips on Q2 2026 miss, cuts outlook

LeMaitre Vascular reported a Q2 2026 earnings and revenue miss, leading to a significant after-hours stock drop. Despite strong year-over-year growth and margin expansion, the company cut its full-year organic revenue growth outlook due to foreign exchange pressures, Middle East shipping delays, and cardiac …

LeMaitre says Artegraft is now approved in 56 countries

LeMaitre (NASDAQ: LMAT) reported strong Q2 2026 financial results with net sales up 10% year-over-year to $70.4 million and diluted EPS up 23% to $0.74. A key growth driver was Artegraft, whose sales increased by 34%, now representing 21% of total sales and approved …

Athabasca Oil Corporation Buys 36,800 Shares of Athabasca Oil (TSE:ATH) Stock

Athabasca Oil Corporation Acquires 39,500 Shares of Athabasca Oil (TSE:ATH) Stock

Earnings call transcript: Boise Cascade beats on Q2 2026 results, shares rise

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 14.61% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (LMAT) is a significant player in the healthcare sector, specifically in medical instruments for vascular surgery, with a market capitalization of $2.37 billion. The company shows strong financial health with 11.20% revenue growth, a 16.55% return on equity, and a forward …

LeMaitre Vascular earnings on deck as margin gains test continues

LeMaitre Vascular is set to announce its second-quarter earnings, with investors closely watching its ability to maintain significant margin expansion and accelerate profit growth. Analysts anticipate earnings of $0.81 per share on revenue of $71.5 million, reflecting substantial year-over-year growth. The company's premium valuation …

Boise Cascade Q2 2026 slides: earnings beat, James Hardie deal

Boise Cascade (NYSE:BCC) reported stronger-than-expected Q2 2026 results, with earnings significantly exceeding analyst estimates despite a challenging housing market. The company also announced a major strategic partnership expansion, becoming the sole nationwide distributor for James Hardie's expanded product portfolio, which drove a positive investor …

LeMaitre Q2 2026 Financial Results

LeMaitre Vascular, Inc. reported strong Q2 2026 financial results with sales up 10% to $70.4 million and EPS up 23% to $0.74, driven by a 34% increase in Artegraft sales and operational efficiencies. The company announced a quarterly dividend of $0.25/share and provided optimistic …

LeMaitre: Q2 Earnings Snapshot

LeMaitre Vascular Inc. (LMAT) reported a second-quarter profit of $17.1 million, or 74 cents per share, on revenue of $70.4 million. The medical device maker anticipates revenue for the current quarter to be between $66.3 million and $68.3 million, with full-year earnings projected at …

Athabasca Oil (TSX:ATH) Guidance Reshapes Market Debate

The Gross Law Firm Reminds Erasca, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ERAS

The Gross Law Firm is reminding investors of Erasca, Inc. (ERAS) about a pending class action lawsuit. Shareholders who purchased ERAS shares between January 14, 2025, and April 26, 2026, are encouraged to contact the firm regarding potential lead plaintiff appointment. The lawsuit alleges …

MONDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased Erasca common stock between January 14, 2025, and April 26, 2026, and suffered substantial losses, …

Masco CFO to Join Live Investor Chat From Chicago Aug. 11

Masco Corporation announced that its Vice President, Chief Financial Officer, and Treasurer, Rick Westenberg, will participate in a fireside chat at the Deutsche Bank Chicago Industrials Summit 2026. The event is scheduled for Tuesday, August 11, at 11:00 a.m. ET, and will be webcast …

Masco Corporation to Participate in a Fireside Chat at an Investor Conference

LIVONIA, Mich., August 04, 2026--(BUSINESS WIRE)--Masco Corporation (NYSE: MAS) announced today that Rick Westenberg, Vice President, Chief Financial Officer and Treasurer, will participate in a fireside chat at the Deutsche Bank Chicago Industrials Summit 2026 in Chicago, Illinois on Tuesday, August 11, at 11:00 …

LeMaitre Vascular, Inc. $LMAT Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 34.9% in the first quarter, selling 27,990 shares and retaining 52,252 shares valued at approximately $5.7 million. The medical instruments supplier reported strong Q1 earnings, beating estimates with $0.68 EPS …

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6%

LeMaitre (NASDAQ:LMAT) Misses Q2 CY2026 Revenue Estimates, Stock Drops 11.6% Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street's revenue expectations in Q2 CY2026, but sales rose 9.6% year on year to $70.38 million. Next quarter's revenue guidance of $67.3 million underwhelmed, coming in …

LeMaitre Vascular (NASDAQ:LMAT) Posts Earnings Results